Dalbavancin in real life: Economic impact of prescription timing in French hospitals

Guillaume Béraud, Jean-Claude Maupetit, Audric Darras, Alexandre Vimont, Martin Blachier
doi: https://doi.org/10.1101/2021.07.24.21259935

Article Information

doi 
https://doi.org/10.1101/2021.07.24.21259935
History 
  • July 28, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Guillaume Béraud1,*,
  2. Jean-Claude Maupetit2,
  3. Audric Darras3,
  4. Alexandre Vimont4 and
  5. Martin Blachier4
  1. 1Department of Internal Medicine and Infectious Diseases, University Hospital of Poitiers, Poitiers, France
  2. 2Hospital pharmacy, University Hospital of Nantes, Nantes, France
  3. 3UNIHA Tender, Hospital pharmacy, University Hospital of Toulouse, Toulouse, France
  4. 4Public Health Expertise, Paris
  1. ↵*Corresponding author; email: beraudguillaume{at}gmail.com
Back to top
Posted July 28, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Dalbavancin in real life: Economic impact of prescription timing in French hospitals
Guillaume Béraud, Jean-Claude Maupetit, Audric Darras, Alexandre Vimont, Martin Blachier
medRxiv 2021.07.24.21259935; doi: https://doi.org/10.1101/2021.07.24.21259935
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area